Drug use and health disparities in 2 Indian populations

描述：(由申请者提供)美国印第安人(AI)青年一贯报告的毒品使用率高于其他国家 美国的人口。此外，人工智能年轻人即使不是更有可能，也同样有可能 所以，要经历吸毒的严重后果。不管剩下多少 未知：现存的文学作品主要局限于人工智能青年和， 一般说来，很少有人关注文化差异。A更多 需要全面说明吸毒的负面后果。 最后，纳入健康的可获得性、可获得性和可接受性 有必要为了解健康差距提供服务。这 提案回应RFA DA-01-008，计划在以下方面取得重大进展 描绘和理解这些差异。最近完成的数据 美国印第安人服务利用、精神病学流行病学和 风险/保护因素项目(AI-SUPERPFP)提供了更好的机会 了解两个最大的部落之间与毒品有关的健康差距 人口。具体目标是：1)开发生物心理社会模型 了解药物使用中的健康差异的重要因素及其 不利的后果。2)描述药物使用方面的差异 (包括烟草)在两个人工智能种群之间，并进一步调查 生物、心理和社会因素的种族差异可能在多大程度上解释 这些差异。3)描述在行为、社交、 药物使用的医疗和心理健康后果，并调查 生物、心理、社会因素和药物使用差异的解释程度 这些差异。4)描述卫生利用方面的差距 并调查卫生服务之间的关系， 生物心理社会因素、药物使用和不良后果。5)放置这些 在国家背景下的调查结果，并使用明智的比较 全国共病调查(NCS)14-19和全国家庭调查 药物滥用(NHSDA)。 AI-SUPERPFP的拟议分析--第一个大规模的、基于社区的 酒精、药物和精神健康(ADM)对人工智能的流行病学研究承诺 以前所未有的方式提供与毒品相关的健康差距的洞察 可能：首先，彻底调查两个国家的这种差异 最大但在文化上截然不同的部落群体；后来又有针对性的 将这些发现与来自两个可比努力的国家数据进行比较 与全国样本一起。此外，美国印第安人和阿拉斯加州分部 原生计划(DAIANP)提供了独特的多学科环境 (包括心理学、精神病学、内科、人口学、 人类学和公共卫生)进行这项工作，因此很有希望 为更广泛的差异研究提供信息。

DESCRIPTION: (provided by applicant) American Indian (AI) youth consistently report higher use of drugs than other populations in the United States. Further, AI youth are as likely, if not more so, to experience serious consequences from drug use. However much remains unknown: The extant literature is largely restricted to AI youth and, generally, little attention is paid to cultural differences. A more comprehensive description of the negative consequences of drug use is needed. Finally, incorporation of availability, access, and acceptability of health services into the understanding of health disparities is warranted. This proposal responds to RFA DA-01-008 with a plan to make significant progress in depicting and understanding these disparities. Data from the recently completed American Indian Service Utilization, Psychiatric Epidemiology, and Risk/Protective Factors Project (AI-SUPERPFP) provide an opportunity to better understand the drug-related health disparities between 2 of the largest tribal populations. The specific aims are 1) To develop models of the biopsychosocial factors important to understanding health disparities in drug use and its adverse consequences. 2) To depict the disparities in the use of drugs (including tobacco) between 2 AI populations and, further, to investigate the degree to which ethnic differences in biopsychosocial factors may account for these disparities. 3) To depict the disparities in the behavioral, social, medical, and mental health consequences of drug use and to investigate the degree to which differences in biopsychosocial factors and drug use explain these disparities. 4) To describe the disparities in utilization of health services and to investigate the relationships of health services, biopsychosocial factors, drug use, and adverse consequences. 5) To place these findings in a national context with the use of judicious comparisons to the National Comorbidity Survey (NCS) 14-19 and the National Household Survey of Drug Abuse (NHSDA). The proposed analyses of AI-SUPERPFP--the first large-scale, community-based alcohol, drug and mental health (ADM) epidemiologic study of AIs promises to provide insights drug-related health disparities in a manner never before possible: first with a thorough investigation of such disparities across two of the largest, but culturally distinct, tribal groups; and later with targeted comparisons of these findings with national data from two comparable efforts with national samples. Furthermore, the Division of American Indian and Alaska Native Programs (DAIANP) provides a unique multidisciplinary environment (including staff from psychology, psychiatry, internal medicine, demography, anthropology, and public health) in which to conduct this work, thus promising to inform disparities research more generally.